SYED ANWAR: Open Payments
NPI 1477622819 · ELGIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,274 in 154 payments from 19 companies in 2025. Trend: 2023 $3,472 · 2024 $3,589 · 2025 $3,274
Food & beverage: $3,139Education: $134
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 20 | $534 |
| Neurocrine BioSciences, Inc. | 23 | $415 |
| Lundbeck LLC | 15 | $295 |
| ABBVIE INC. | 14 | $293 |
| Teva Pharmaceuticals USA, Inc. | 16 | $291 |
| Axsome Therapeutics, Inc. | 9 | $274 |
| Otsuka America Pharmaceutical, Inc. | 12 | $221 |
| E.R. Squibb & Sons, L.L.C. | 12 | $201 |
| HARMONY BIOSCIENCES LLC | 5 | $181 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $121 |
Products named: HETLIOZ, INGREZZA, VRAYLAR, REXULTI, ABILIFY ASIMTUFII, COBENFY, Auvelity, AUSTEDO XR.
Industry payments across IL — which companies pay providers there.
